Señales en vivo de 688670.SS | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 03:00):

Stats
Volumen de hoy	528 259
Volumen promedio	856 465
Capitalización de mercado	2.08B
EPS	CNY0 ( 2023-10-27 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	-16.10
ATR14	CNY0.0170 (0.10%)

Volumen Correlación

Largo: -0.16 (neutral)

Corto: -0.11 (neutral)

Signal:(41.816) Neutral

Jiangsu gdk Biotechnology Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Jiangsu gdk Biotechnology Correlación - Moneda/Commodity

-0.53
( weak negative )

-0.46
( neutral )

0.00
( neutral )

-0.44
( neutral )

-0.41
( neutral )

0.59
( weak )

Jiangsu gdk Biotechnology Finanzas

Annual	2023
Ingresos:	CNY139.97M
Beneficio Bruto:	CNY110.10M (78.66 %)
EPS:	CNY-0.540

FY	2023
Ingresos:	CNY139.97M
Beneficio Bruto:	CNY110.10M (78.66 %)
EPS:	CNY-0.540

FY	2022
Ingresos:	CNY318.49M
Beneficio Bruto:	CNY267.90M (84.12 %)
EPS:	CNY0.340

FY	2021
Ingresos:	CNY392.27M
Beneficio Bruto:	CNY335.09M (85.42 %)
EPS:	CNY1.100

Financial Reports:

No articles found.

Jiangsu gdk Biotechnology

Jiangsu gdk Biotechnology Co., Ltd., a biological company, engages in the scientific research, production, operation, and service of human vaccines. The company offers quadrivalent influenza virus split and lyophilized human rabies vaccines. Its product pipeline has coverage for the prevention of principal infectious diseases, including influenza, rabies, chickenpox, shingles, and pneumonia. The company was founded in 2008 and is based in Taizhou, China.